Product
Fluorine F 18 DASA-23
1 clinical trial
3 indications
Indication
Healthy SubjectIndication
Intracranial NeoplasmIndication
GlioblastomaClinical trial
A Phase I Study of [18F]DASA-23 as a PET Tracer for Evaluating Pyruvate Kinase M2 (PKM2) Expression in Healthy Volunteers and in Patients With Intracranial TumorsStatus: Completed, Estimated PCD: 2022-12-31